Telomir Pharmaceuticals reports Telomir-1 restores mitochondrial function without cell division in Progeria study

Telomir Pharmaceuticals, Inc.

Telomir-1 increased mitochondrial energy (WST-1 assay) and reduced ROS under basal and stress conditions.
No increase in live cell number was observed, confirming no stimulation of cell proliferation.
Activity was greater in Progeria fibroblasts than in healthy cells, suggesting disease-selective effects.
Results may inform development in Parkinson's, ALS, Alzheimer's, Werner's, and Progeria.
IND-enabling studies for Telomir-1 are ongoing; clinical path evaluation continues.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.